Search Medical Condition
Please enter condition
Please choose location

Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (736) clinical trials

The study will include men and pre- and postmenopausal women with HR-positive, HER2- negative high risk EBC after adequate surgical resection, radiotherapy (if indicated), adjuvant or neo-adjuvant chemotherapy, and who are deemed to be eligible for adjuvant ET for at least 60 months of duration.

Phase

The target population for this study is women who are candidates to receive single agent fulvestrant endocrine therapy for metastatic, ER/PR+ and HER2 negative breast cancer. Such patients shall not have received prior treatment with chemotherapy in the locally advanced or metastatic disease setting and must have failed prior systemic ...

Phase

Study Description: The purpose of the study is to learn about how light therapy affects post-treatment symptoms and well-being in breast cancer survivors. It will also look at how easy or difficult it is for patients to use at home. This study will take about 3 weeks. There is 1 ...

Phase N/A

Women with Breast Cancer are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

People with Breast Cancer are asked to participate in a research study being conducted by White Plains Hospital. Eligibility criteria (inclusion and exclusion): You may be eligible to participate in this study if you: • Are a male or female at least 18 years of age • Have confirmed diagnosis ...

Phase N/A

People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center. Eligibility criteria (inclusion and exclusion) You may be eligible to participate in this study if you: • Are at least 18 years of age or older • Have been diagnosed with HER2-negative ...

Phase N/A

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

Estrogen hormone receptor-positive metastatic breast cancer who failed to non steroidal aromatases inhibitors in patients who are eligible for everolimus+exemestane treatment

Phase N/A

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

This research study is a Phase I/II clinical trial. Phase II clinical trial tests the safety and effectiveness of an investigational intervention to learn whether the intervention works in treating a specific disease. "Investigational" means that the intervention is being studied. It also means that the FDA (the U.S. Food ...

Phase

Women's Triple-Negative First-Line Study: Liposomal Doxorubicin Bevacizumab and Everolimus (DAE) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy

Study Drug Administration: If you are found eligible to take part in this study, you will have 4 cycles of chemotherapy before surgery. Each cycle is 21 days. On Day 1 of each cycle, you will receive liposomal doxorubicin by vein over about 3 hours, and bevacizumab by vein over ...

Phase

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

PRIMARY OBJECTIVES: I. To determine the safety and tolerability of taselisib given in combination with enzalutamide: Assessment of dose limiting toxicities (DLTs) during the first 4 weeks of treatment (cycle 1). (Phase Ib) II. To determine the safety and tolerability of taselisib given in combination with enzalutamide: Determination of the ...

Phase